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Presentation 
A 77-year-old man with a history of diffuse large cell B-cell lymphoma (DLBCL) and 7 cycles of 
chemotherapy (CHOP) plus rituximab presented to the dermatology clinic with a nodule overlying the 
left 5th dorsal metacarpal phalangeal joint of 2-3 months duration.  The nodule was pink and rubbery, 
fixed in place with overlying scale and crusting.  There was initial concern for a skin cancer given his 
history of actinic keratoses and 4 prior skin cancers in the past. He had intermittent sweating and weight 
loss that occurred during his chemotherapy cycles, but not otherwise. During one of his hospitalizations 
he had developed atrial fibrillation and was prescribed amiodarone.  On review of symptoms, he 
mentioned having an occasional headache and sinusitis like symptoms.  He did not have any neck 
stiffness, paralysis, paresthesias, diplopia, nor history of seizures. 
Assessment 
On exam, he had a scaly rubbery pink-brown nodule to the left dorsal hand with some heme crust at the 
center of the lesion—this lesion was non-tender (see Figure 1).  At the left forearm there were a series 
of 3 rubbery pink-brown non-crusted papules, linearly arranged (see Figure 2).  These were non-tender 
as well.  When questioned about these papules, he noted that they occurred approximately 18 months 
ago after he was receiving intravenous contrast for a CT scan being done for the purpose of staging his 
lymphoma. A few days after the intravenous contrast was given, he participated in a home renovation 
that resulted in exposure to dusty conditions during the demolition phase.  The lesions were non-tender 
to palpation and he regarded them as scars.  He had neither epitrochlear nor axillary lymphadenopathy 
on his left side. 
Given the uncertain differential diagnosis of the lesion on left dorsal hand and the curious linear 
arrangement of the forearm papules, a biopsy of each lesion was performed to evaluate for either a 
cutaneous malignancy (such as a squamous cell carcinoma) or an infectious etiology occurring in a 
sporotrichoid distribution, such as sporotrichosis, mycobacterial infection, other deep fungal infections 
including histoplasmosis and blastomycosis.  Iododerma given the history of IV contrast was also 
considered. 
The biopsy of both locations showed pseudoepitheliomatous hyperplasia with neutrophilic and 
granulomatous inflammation.  Closer examination demonstrated pigmented hyphae in both the hand 
and forearm specimens (Figure 3 and 4). Skin tissue was cultured, and Exophiala jeanselmei was found. 
Diagnosis 
The patient was diagnosed with phaeohyphomycosis. Phaeohyphomycosis is caused by dematiaceous 
fungi from genera such as Exophiala, Cladosporium, Phialophora and Wangiella, which live worldwide in 
soil, trees, and decaying vegetation (1). Infection with such organisms can usually be traced to 
inoculation, from a source as simple as a splinter. Most infected patients had a history of working 
outdoors with light clothing (2) (3) (4) (5). Skin manifestations, including rash and ulcers, are commonly 
seen in patients, along with fever (6). Diagnosis of phaeohyphomycosis caused by E. jeanselmei involves 
both the presence of positive cultures and histopathologic evidence. Typical changes involve a 
granulomatous tissue response with infiltration of leukocytes and occasionally microabscess formation. 
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Microscopically, Exophiala initially appears as budding yeast-like cells that often form long chains. As 
they mature, septate hyphae, brown to black in color, develop that give rise to numerous tubular cells 
called annelides. These annelides usually narrow out and form elongated tips, which help to distinguish 
Exophiala from other dematiaceous fungi. (7) (8). Subcutaneous phaeohyphomycosis can occur in both 
immunocompetent and immunosuppressed patients (including solid organ transplant recipients and 
those being treated with corticosteroid); immunosuppression poses a greater risk of treatment failure 
and subsequent dissemination of the infection (9). Because phaeohyphomycosis often disseminates to 
many organs, cardiac and cerebral tissue can be involved, resulting in high mortality (case series report 
80%) particularly if the central nervous system is affected (10).  While there is no standard workup for 
phaeohyphomycosis infection, if the central nervous system is evaluated, MRI is the imaging modality of 
choice; MRI with diffuse weighted imaging and MR perfusion studies may even be useful in 
differentiating fungal central nervous system infections from pyogenic or neoplastic causes (11). 
 
Management  
For invasive and disseminated disease due to phaeohyphomycosis, surgical excision, if possible, should 
generally be combined with antifungal therapy. Itraconazole at doses of 400 mg/day or higher for at 
least 6 months is commonly used in treating this group of infections. Case reports have also 
demonstrated success with itraconazole and terbinafine, or voriconazole and terbinafine (12). For 
central nervous system disease, posaconazole has been effective, as have combinations of amphotericin 
B, flucytosine, and itraconazole. Complete excision of primary brain lesions may be prudent (10). In 
widely disseminated disease, debulking of skin may be of some value (6). 
Our patient may have had an inoculation after developing a wound from the IV contrast extravasation 
and participating in the renovation of a dusty building. Due to a potential interaction with azole 
antifungal (itraconazole, voriconazole) and the patient’s amiodarone, oral terbinafine 250 mg daily was 
used.  After 2 weeks, on follow-up, however, the patient noted that the lesions had increased in size, 
had become tender, and he felt the treatment was failing. Given his continued headaches and sinusitis, 
he received an MRI of the brain with contrast, which did not show central nervous system involvement.  
With the progression of the lesions, terbinafine and amiodarone were discontinued, and the patient was 
started on voriconazole 200 mg twice a day.  After 6 weeks of therapy, the pain associated with the 
lesions lessened and the lesions flattened.  He continued voriconazole for a full 12 week course, with 
only the side effect of mild vision blurring.  He has been followed clinically for the past year without 
evidence of recurrence. 
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Figure Legends 
 
Figure 1: Crusted nodule with ulceration 
Figure 2: Lesions on the hand and the forearm 
Figure 3: 60X magnification of H/E of hand biopsy, granulomatous and suppurative inflammation and 
subtle pigmented hyphae (arrows). 
Figure 4:  PAS staining of hand biopsy (60X magnification) showing pigmented hyphae. 
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